Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.5 USD | -2.17% | +6.67% | -10.58% |
05-16 | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |
05-15 | Transcript : Abeona Therapeutics Inc., Q1 2024 Earnings Call, May 15, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.58% | 182M | |
+32.63% | 50.85B | |
+0.18% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.95% | 26.11B | |
-22.13% | 19.13B | |
+8.22% | 13.05B | |
+27.57% | 12.16B | |
+24.59% | 12.08B |
- Stock Market
- Equities
- ABEO Stock
- News Abeona Therapeutics Inc.
- Abeona Therapeutics : HC Wainwright Adjusts Abeona Therapeutics' Price Target to $8 From $11, Keeps at Buy